soc datapharm
Datapharm operates emc, the UK's leading online medicines information repository serving 320+ pharma companies and 26M users. It provides FHIR-structured data, regulatory publishing tools, and B2B SaaS modules for pharmaceutical regulatory, medical information, and commercial teams.
- Company typePrivate
- Founded1977
- HeadquartersLeatherhead, United Kingdom
- Headcount51–100
- GTM typeB2B
- OfferingSoftware
What soc datapharm does
Datapharm Limited is a UK-based, privately-held medicines information software and evidence-generation company founded in 1977 and headquartered in Leatherhead, Surrey. The company operates emc (electronic medicines compendium), the UK's primary online repository of medicines information, hosting SmPCs, Patient Information Leaflets, Risk Minimisation Materials, and Scientific Response Documents for over 10,000 medicines from more than 320 pharmaceutical companies. The platform serves 26 million users annually with 85 million visitors, and is trusted by 97% of UK healthcare professionals as their first-choice medicines information resource. Datapharm's core technology stack includes a FHIR-structured data platform (fully migrated in March 2024) that enables interoperability with NHS systems including the dm+d database, GP, hospital, and pharmacy IT systems.
The company's product portfolio extends beyond emc into a suite of B2B enterprise software modules sold to pharmaceutical companies: emc regulatory for content publishing and ePIL conversion, emc compliance for sales and marketing compliance, emc market access with NHS dm+d tools and Product Information Management, emc market intelligence for HCP engagement analytics, emc publisher for SmPC submission workflows with automated quality checks, emc pi portal for prescribing information management, and emc icomply for field sales user management. Revenue is generated through subscription and licensing agreements with pharma companies on an annual billing cycle, with pricing negotiated enterprise-style via Key Account Managers.
Datapharm's go-to-market combines direct enterprise sales to pharma companies with distribution partnerships (Pharmaceutical Press/M MedicinesComplete, Rote Liste in Germany, MILE for broader European access via migateway). The company has no disclosed external funding, operates without a parent company, and has been actively expanding internationally (European expansion via Rote Liste partnership, October 2024) and technologically (MCP server prototype for AI agents, December 2025). NHS healthcare organizations including NHS BSA, NHS SPS, NHS Medusa, and NICE are key downstream consumers of emc data feeds, embedding the platform deeply in UK healthcare infrastructure.
soc datapharm firmographics
Firmographics- Name
- soc datapharm
- Legal name
- Datapharm Limited
- Website
- https://datapharm.org.uk
- Company type
- Private
- Founded year
- 1977
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Datapharm operates emc, the UK's leading online medicines information repository serving 320+ pharma companies and 26M users. It provides FHIR-structured data, regulatory publishing tools, and B2B SaaS modules for pharmaceutical regulatory, medical information, and commercial teams.
- Ownership category
- akta.pro rank
soc datapharm industry classification
Industry- Product category
- Pharmaceutical Medicines Information Software
- NAICS
- Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (518), Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (51821)
- SIC
- Services-Computer Programming, Data Processing, Etc. (7370)
- akta.pro primary industry
- FHIR/HL7 Data Repositories & Canonical Data Models (HLACAIAI)
- akta.pro secondary industries
- Healthcare Master Data Management (MDM) & Patient/Provider Identity Data (HLACAIAB), Consent, Preference & Data Rights Management (incl. HIPAA/GDPR support) (HLACAIAG)
Keywords
Where soc datapharm is headquartered
LocationHeadquarters
- HQ city
- Leatherhead
- HQ country
- United Kingdom
- HQ region
- Europe
Offices1 record
Markets served
soc datapharm business model
Business model- GTM type
- B2B
- Offering type
- Software
Revenue model
- emc Platform Subscription / Membership: Pharma companies subscribe to emc for publishing and distributing medicines information. Trusted by over 320 pharma companies as their primary source of medicines safety information. Pricing appears to be quote-based/membership model.
- Technology Solutions Licensing: Licensing of emc regulatory, compliance, market access, and market intelligence solutions to pharmaceutical companies for managing product information.
- SRD Services: Scientific Response Document service enabling pharma to make medical information searchable by HCPs on emc.
- MedicinesComplete Distribution: Partnership with Pharmaceutical Press to provide emc access through MedicinesComplete platform to international users outside the UK.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Quote-based enterprise pricing for pharma companies |
Go-to-market motion2 records
Distribution channels5 records
Marketing channels7 records
soc datapharm product offering
Product offeringCore offering
Datapharm operates emc (electronic medicines compendium), the UK's trusted online repository for medicines information since 1977. The company provides software solutions that enable pharmaceutical companies to publish, manage and distribute SmPCs, Patient Information Leaflets and Risk Minimisation Materials, while supplying healthcare professionals and patients with accessible, FHIR-structured medicines data. Datapharm also delivers adjacent solutions covering compliance, market access (NHS dm+d integration), market intelligence, regulatory publishing workflows and Scientific Response Document (SRD) search services.
Product overview
Datapharm operates emc (electronic medicines compendium) as the core platform, serving as the UK's trusted resource for up-to-date medicines information since 1977. The emc platform hosts medicines data from over 320 Pharma companies with 26M annual users. Around this core, Datapharm offers a suite of integrated solutions: emc regulatory for content publishing and ePIL conversion, emc compliance for sales and marketing compliance, emc market access with NHS dm+d tools and Product Information Management, emc market intelligence for engagement analytics, emc publisher for SmPC submission workflows, emc pi portal for prescribing information management, emc icomply for field sales teams, and emc intelligence for change monitoring. The Scientific Response Documents (SRDs) service enables HCPs to self-search Pharma-provided medical information beyond the SmPC. The company is transitioning to FHIR-structured data formats to improve healthcare system interoperability and support AI-powered medicines information retrieval.
Differentiator
Problem solved
Functional benefit
Products and services
- emc (electronic medicines compendium) The UK's primary online repository for medicines information, hosting SmPCs, Patient Information Leaflets (PILs), electronic Patient Information Leaflets (ePILs) and Risk Minimisation Materials (RMMs) from over 320 pharmaceutical companies. Trusted by 26M users annually and 97% of UK HCPs.
- emc regulatory Solution module enabling pharmaceutical regulatory teams to publish and deliver product safety information to patients in required formats, including conversion of PILs to electronic Patient Information Leaflets (ePILs).
- emc compliance Compliance solution enabling Pharma Sales & Marketing teams and Regulatory departments to stay compliant by ensuring content provides up-to-date and accurate product information.
- emc market access Market access solution including tools for working with NHS dm+d (Dictionary of Medicines and Devices) and a Product Information Management (PIM) platform for teams managing information flow in the supply chain.
- emc market intelligence Market intelligence solution enabling Pharma Sales & Marketing teams to understand how HCPs engage with relevant product information and keep track of medicine information changes.
- emc publisher Regulatory publishing tool for pharmaceutical companies to submit and manage SmPCs and product information on emc, including automated quality checks, PDF generation at approval stage and change broadcast functionality.
- Scientific Response Documents (SRDs) Self-service search service enabling HCPs to find answers to frequently asked questions about medicines beyond the SmPC and PIL. Answers are uploaded by Pharma companies and made searchable 24/7 on emc.
- emc pi portal Prescribing Information management portal helping pharmaceutical companies save tens of thousands when updating and sharing prescribing information, with automation, improved audit-readiness and simplified workflows.
- emc icomply User management interface for Field Sales teams sharing product information with HCPs, supporting compliant distribution of approved pharmaceutical product information.
- emc intelligence Market intelligence solution providing automated medicine updates specific to user interests, featuring a medicine change dashboard for monitoring SmPC and PIL updates over time.
Quantifiable outcome
- 8.7M Patient information leaflets downloaded in 2025
- +5 more outcomes
Companies that use soc datapharm
Customer profileNamed customers22 records
Segments7 records
Ideal customer profiles3 records
soc datapharm technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration9 records
AI capability5 records
Feature10 records
soc datapharm partnerships and signals
Strategic signalPartnerships
Nine partnerships are on record, tiered core, supporting, strategic and regulatory.
- Rote ListecorePartnership with Rote Liste, a leading provider of medicines information in Germany with 90 years of reliability, to provide SRD search functionality to HCPs in Germany. Already secured contracts with four world-leading pharmaceutical companies. This is part of Datapharm's European expansion strategy.
- MILE (Medical Information Leaders in Europe)coreEnhanced partnership with MILE to make weblinks to emc available on migateway (www.migateway.eu), a centralised medicines information resource for Europe. Collaboration enables more HCPs to access trusted medicines information from an independent, one-stop-shop. MILE represents 33 pharma company members across Europe.
- Original DigitalsupportingHealthcare technology company partner that helped develop the SRD search service on emc. Original Digital helps businesses understand the value of medical projects, implementing them compliantly and cost-effectively.
- Pharmaceutical Press (Royal Pharmaceutical Society)corePartnership adding emc to MedicinesComplete platform. Users can easily search emc information with direct links to British National Formulary (BNF) clinical guidance. emc through MedicinesComplete includes printable patient information leaflets and full SmPC documents. Available to all countries outside UK on subscription from October 2022.
- Sustainable Medicines PartnershipstrategicNot-for-profit private-public collaboration executing projects to make the use of medicines more sustainable and less wasteful, led by YewMaker. Datapharm contributes expertise in electronic patient information and data on industry adoption of ePILs.
- Gravitate-HealthstrategicResearch consortium funded by Innovative Medicines Initiative (IMI), a joint undertaking of the European Commission. Partners with 40+ organizations from public and private sectors in 15 countries to develop innovative patient-focused healthcare information tools. Project led by Pfizer and coordinated by University of Oslo. Datapharm contributes expertise in medicines data structuring and ePI implementation.
- NHS (NHS BSA, NHS SPS, NHS Medusa, NICE)coreNHS healthcare services rely on emc as a pivotal source for maintaining digital healthcare information resources. NHS BSA uses emc for dm+d database; NHS SPS uses for NICE Medicines Awareness Service and Refrigerated Medicines Stability Tool; NHS Medusa uses for Injectable Medicines Guide. emc change reports enable these services to stay updated with medicines information changes.
- MHRA (Medicines and Healthcare products Regulatory Agency)regulatoryUK regulator confirmed no opposition to the SRD pilot on emc, provided the solution was compliant with relevant industry codes and regulations. Ongoing regulatory relationship for medicines information standards.
- UK Electronic Patient Information TaskforcestrategicUK industry taskforce bringing together pharma leaders to support digital use of medicine product information. Includes representatives from Pfizer, BGMA. Working to involve NHS England and MHRA. Taskforce aims to facilitate user-centred, digital-first medicines information that is inclusive and accessible.
Scale indicators11 records
Recent moves6 records
Expansion highlights6 records
soc datapharm competitors and assessment
Company assessmentDirect peers
- Veeva Systems: Veeva's Vault RIM and Vault PromoMats suites provide regulatory information management and content compliance for pharma — overlapping directly with Datapharm's emc regulatory, compliance, and publisher modules, though at far greater scale and global footprint.
- Cegedim: Cegedim's Life Sciences division offers regulatory affairs, promotional compliance, and medical information management software (e.g., THIN, Customer Information System) — directly competing with Datapharm's emc compliance and SRD services, particularly in European markets.
- ArisGlobal: ArisGlobal provides life sciences regulatory affairs, pharmacovigilance, and document management platforms (LifeSphere) that compete with emc regulatory and publisher workflows for pharma customers globally.
- Phlexglobal: Phlexglobal (a Cencora company) specializes in regulatory document management and submission-ready TMF/eTMF content — closely comparable to emc publisher's regulatory submission and SmPC management capabilities.
- Rote Liste: Rote Liste is Germany's dominant medicines information provider and a Datapharm partner for SRD distribution into Germany — comparable as a regional medicines compendium operator targeting pharma and HCPs with structured regulatory content.
Broad incumbents
- IQVIA: IQVIA operates a global life sciences data, technology, and services platform including regulatory information management and real-world evidence generation — broadly overlapping with Datapharm's medicines information and market intelligence offerings as part of a much larger portfolio.
- Oracle Health Sciences: Oracle's Health Sciences suite (formerly part of Cerner/Phase Forward) includes clinical and regulatory data management platforms that overlap with emc's enterprise medicines information use cases as part of a broader life sciences portfolio.
- Elsevier (RELX): Elsevier's Clinical Solutions and ClinicalPath products provide evidence-based clinical decision support that integrates with EMR systems — comparable as adjacent healthcare data and evidence-generation platform serving HCPs and pharma with structured content.
Regional players
- Pharmaceutical Press (Royal Pharmaceutical Society): Pharmaceutical Press publishes BNF, Martindale, and Stockley and operates MedicinesComplete — partnering with Datapharm for emc access, but operating adjacent medicines reference content that competes for HCP attention and licensing budgets.
Emerging players
- PharmaLex: PharmaLex provides regulatory affairs consulting and technology-enabled services across pharma — partially overlapping with Datapharm's regulatory solutions and offering similar enterprise pharma customers a different delivery model.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
soc datapharm social profiles
Digital presencesoc datapharm compliance and trust
Trust signalCompliance3 records
soc datapharm financial estimates
Financial estimateRevenue estimate
Valuation estimate
soc datapharm leadership team
Management profileNumber of profiles
soc datapharm funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
soc datapharm M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about soc datapharm
What does soc datapharm do?
Datapharm operates emc (electronic medicines compendium), the UK's trusted online repository for medicines information since 1977. The company provides software solutions that enable pharmaceutical companies to publish, manage and distribute SmPCs, Patient Information Leaflets and Risk Minimisation Materials, while supplying healthcare professionals and patients with accessible, FHIR-structured medicines data. Datapharm also delivers adjacent solutions covering compliance, market access (NHS dm+d integration), market intelligence, regulatory publishing workflows and Scientific Response Document (SRD) search services.
Is soc datapharm a public or private company?
soc datapharm is a private company. It is classified as management employee owned and is currently operating.
When was soc datapharm founded?
soc datapharm was founded in 1977. It employs 51 to 100 people.
Where is soc datapharm based?
soc datapharm is headquartered in Leatherhead, United Kingdom, in the Europe region.
How does soc datapharm make money?
Four revenue lines are on record. emc Platform Subscription / Membership is the primary driver. The others are technology Solutions Licensing, SRD Services and medicinesComplete Distribution.
Who are soc datapharm's main competitors?
Direct peers on record are Veeva Systems, Cegedim, ArisGlobal, Phlexglobal and Rote Liste. Broad incumbents are IQVIA, Oracle Health Sciences and Elsevier (RELX). Pharmaceutical Press (Royal Pharmaceutical Society) is listed as a regional player. PharmaLex is listed as an emerging player.
Does soc datapharm have an API?
No public API is recorded for soc datapharm.
What industry is soc datapharm in?
soc datapharm's product category is Pharmaceutical Medicines Information Software. Its primary akta.pro industry code is HLACAIAI, FHIR/HL7 Data Repositories & Canonical Data Models, with a secondary code of HLACAIAB, Healthcare Master Data Management (MDM) & Patient/Provider Identity Data. Its NAICS code is 518 and its SIC code is 7370.